In this issue: Questioning statins, oil, and paying for
paparazzi.
---Business---
Fast Company reports that Pfizer has devised a new kind of
outsourcing -- just for the time-wasting parts of your job.
http://MagPortal.com/nr/rdir.php?w=327927
similar: http://MagPortal.com/cgi/sim.cgi?w=327927
---Health---
Research suggests that, except among high-risk heart
patients, the benefits of cholesterol-lowering statins such
as Lipitor are overstated, according to BusinessWeek.
http://MagPortal.com/nr/rdir.php?w=327684
similar: http://MagPortal.com/cgi/sim.cgi?w=327684
---Oil---
The Motley Fool says the President's request for increased
OPEC oil output may be difficult to fulfill.
http://MagPortal.com/nr/rdir.php?w=327467
similar: http://MagPortal.com/cgi/sim.cgi?w=327467
---Misc---
Even as real celebrities battle paparazzi on the streets and
in courts for intruding on their lives and trading on their
images, Time Europe says some regular folks have decided
that the attention could be fun - and worth paying up to
$1,500 for.
http://MagPortal.com/nr/rdir.php?w=328012
similar: http://MagPortal.com/cgi/sim.cgi?w=328012
|
